Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drorit Neumann

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Biochemical and Biophysical Research Communications|February 8, 2014
EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferationSusann Reinbothe, Anna-Maria Larsson, Marica Vaapil, et al.
British Journal of Haematology|February 19, 2014
Polycythaemia-inducing mutations in the erythropoietin receptor (EPOR): mechanism and function as elucidated by epidermal growth factor receptor-EPOR chimerasMor Gross, Nathalie Ben-Califa, Mary F McMullin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 30, 2015
Erythropoietin directly stimulates osteoclast precursors and induces bone lossSahar Hiram-Bab, Tamar Liron, Naamit Deshet-Unger, et al.
Pediatric Nephrology (Berlin, Germany)|July 22, 2018
Response to erythropoietin in pediatric patients with chronic kidney disease: insights from an in vitro bioassayRachel Gavish, Salmas Watad, Nathalie Ben-Califa, et al.
Frontiers in Cell and Developmental Biology|June 11, 2021
Quantification of Osteoclasts in Culture, Powered by Machine LearningEdo Cohen-Karlik, Zamzam Awida, Ayelet Bergman, et al.
International Journal of Molecular Sciences|May 31, 2020
Erythropoietin Mediated Bone Loss in Mice Is Dose-Dependent and Mostly IrreversibleAlbert Kolomansky, Sahar Hiram-Bab, Nathalie Ben-Califa, et al.
Scientific Reports|September 6, 2017
Erythropoietin enhances Kupffer cell number and activity in the challenged liverDafna Gilboa, Yasmin Haim-Ohana, Naamit Deshet-Unger, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 16, 2016
Increased EPO Levels Are Associated With Bone Loss in Mice Lacking PHD2 in EPO-Producing CellsMartina Rauner, Kristin Franke, Marta Murray, et al.
International Journal of Molecular Sciences|January 11, 2022
The Non-Erythropoietic EPO Analogue Cibinetide Inhibits Osteoclastogenesis In Vitro and Increases Bone Mineral Density in MiceZamzam Awida, Almog Bachar, Hussam Saed, et al.
Frontiers in Immunology|November 16, 2020
Anti-CD20-Mediated B Cell Depletion Is Associated With Bone Preservation in Lymphoma Patients and Bone Mass Increase in MiceAlbert Kolomansky, Irit Kaye, Nathalie Ben-Califa, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Biochemical and Biophysical Research Communications|February 8, 2014
EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferationSusann Reinbothe, Anna-Maria Larsson, Marica Vaapil, et al.
British Journal of Haematology|February 19, 2014
Polycythaemia-inducing mutations in the erythropoietin receptor (EPOR): mechanism and function as elucidated by epidermal growth factor receptor-EPOR chimerasMor Gross, Nathalie Ben-Califa, Mary F McMullin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 30, 2015
Erythropoietin directly stimulates osteoclast precursors and induces bone lossSahar Hiram-Bab, Tamar Liron, Naamit Deshet-Unger, et al.
Pediatric Nephrology (Berlin, Germany)|July 22, 2018
Response to erythropoietin in pediatric patients with chronic kidney disease: insights from an in vitro bioassayRachel Gavish, Salmas Watad, Nathalie Ben-Califa, et al.
Frontiers in Cell and Developmental Biology|June 11, 2021
Quantification of Osteoclasts in Culture, Powered by Machine LearningEdo Cohen-Karlik, Zamzam Awida, Ayelet Bergman, et al.
International Journal of Molecular Sciences|May 31, 2020
Erythropoietin Mediated Bone Loss in Mice Is Dose-Dependent and Mostly IrreversibleAlbert Kolomansky, Sahar Hiram-Bab, Nathalie Ben-Califa, et al.
Scientific Reports|September 6, 2017
Erythropoietin enhances Kupffer cell number and activity in the challenged liverDafna Gilboa, Yasmin Haim-Ohana, Naamit Deshet-Unger, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 16, 2016
Increased EPO Levels Are Associated With Bone Loss in Mice Lacking PHD2 in EPO-Producing CellsMartina Rauner, Kristin Franke, Marta Murray, et al.
International Journal of Molecular Sciences|January 11, 2022
The Non-Erythropoietic EPO Analogue Cibinetide Inhibits Osteoclastogenesis In Vitro and Increases Bone Mineral Density in MiceZamzam Awida, Almog Bachar, Hussam Saed, et al.
Frontiers in Immunology|November 16, 2020
Anti-CD20-Mediated B Cell Depletion Is Associated With Bone Preservation in Lymphoma Patients and Bone Mass Increase in MiceAlbert Kolomansky, Irit Kaye, Nathalie Ben-Califa, et al.
Pageof 6